Volume 44, Issue 2, Pages (February 2006)

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Apoptotic pathway activation from mitochondria and.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 59, Issue 5, Pages (May 2001)
Hepatitis C and Alcohol Exacerbate Liver Injury by Suppression of FOXO3  Batbayar Tumurbaatar, Irina Tikhanovich, Zhuan Li, Jinyu Ren, Robert Ralston,
Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression 
Volume 117, Issue 1, Pages (July 1999)
Volume 130, Issue 1, Pages (January 2006)
Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma.
Volume 44, Issue 5, Pages (May 2006)
Volume 42, Issue 3, Pages (March 2005)
How cells die: Apoptosis pathways
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway  Tatsuo Nakahara, M.D., Akira Iwase, M.D., Ph.D.,
Volume 42, Issue 1, Pages (January 2005)
Volume 117, Issue 3, Pages (September 1999)
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
H.T. Lee, M. Kim, M. Jan, R.B. Penn, C.W. Emala  Kidney International 
Volume 44, Issue 2, Pages (February 2006)
Volume 44, Issue 2, Pages (February 2006)
Volume 64, Issue 1, Pages (January 2016)
Volume 123, Issue 2, Pages (August 2002)
Volume 42, Issue 1, Pages (January 2005)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Angiogenesis in liver disease
Volume 44, Issue 1, Pages (January 2006)
Volume 67, Issue 6, Pages (December 2017)
Volume 64, Issue 1, Pages (July 2003)
Volume 42, Issue 2, Pages (February 2005)
L.-H. Weng, C.-J. Wang, J.-Y. Ko, Y.-C. Sun, Y.-S. Su, F.-S. Wang 
Volume 42, Issue 4, Pages (April 2005)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 132, Issue 7, Pages (June 2007)
Volume 136, Issue 4, Pages (April 2009)
Volume 73, Issue 5, Pages (March 2008)
Volume 137, Issue 3, Pages (September 2009)
Volume 126, Issue 1, Pages (January 2004)
Volume 29, Issue 4, Pages (April 2016)
Volume 134, Issue 3, Pages (March 2008)
Volume 73, Issue 4, Pages (February 2008)
Volume 69, Issue 2, Pages (August 2018)
Volume 120, Issue 5, Pages (April 2001)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 59, Issue 5, Pages (May 2001)
JNK mediates hepatic ischemia reperfusion injury
Volume 61, Issue 6, Pages (December 2014)
Volume 41, Issue 6, Pages (December 2004)
BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non- small Cell Lung Carcinoma In Vitro  Wenyan Li, MD, PhD, Bo Li, MD,
Volume 134, Issue 4, Pages (April 2008)
Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma.
Bax Activation and Induction of Apoptosis in Human Keratinocytes by the Protein Kinase C δ Catalytic Domain  Leonid A. Sitailo, Shalini S. Tibudan, Mitchell.
A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis
Superoxide-induced apoptosis of activated rat hepatic stellate cells
Volume 73, Issue 5, Pages (March 2008)
Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small- Molecule Immune Response Modifier Imiquimod  Michael P. Schön, B. Gregor.
Volume 117, Issue 1, Pages (July 1999)
Volume 59, Issue 2, Pages (August 2013)
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Volume 57, Issue 3, Pages (March 2000)
Death receptor-mediated apoptosis and the liver
Volume 41, Issue 6, Pages (December 2004)
Genetic deficiency of adiponectin protects against acute kidney injury
Jacqueline M. Saito*, Jacquelyn J. Maher‡  Gastroenterology 
Volume 76, Issue 7, Pages (October 2009)
Volume 2, Issue 6, Pages (June 2008)
Volume 61, Issue 6, Pages (December 2014)
Volume 82, Issue 3, Pages (August 2012)
Volume 41, Issue 6, Pages (December 2004)
Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells  Udo K. Meßmer, Verena A. Briner, Josef.
Volume 62, Issue 6, Pages (June 2015)
Pathogenesis of cholestatic hepatitis C
Presentation transcript:

Volume 44, Issue 2, Pages 359-367 (February 2006) Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity  Jennifer C. Hanson, Michele K. Bostick, Carson B. Campe, Pratima Kodali, Gene Lee, Jim Yan, Jacquelyn J. Maher  Journal of Hepatology  Volume 44, Issue 2, Pages 359-367 (February 2006) DOI: 10.1016/j.jhep.2005.06.022 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Liver histology in Gal/ET-treated WT and IL-8 TG mice. Photomicrographs depict livers from WT and IL-8 TG mice 6h after administration of Gal/ET. Panel a, WT H&E; panel b, IL-8 TG H&E; panel c, WT TUNEL; panel d, IL-8 TG TUNEL. In WT mice, Gal/ET caused widespread nuclear condensation and fragmentation and diffuse intraparenchymal hemorrhage (a). TUNEL-positive nuclei were prominent throughout the liver lobule (c). In IL-8 TG mice, nuclear condensation was mild, and there was no evidence of intraparenchymal hemorrhage (b). TUNEL-positive nuclei were present in IL-8 TG livers but were sparse in comparison to WT livers. Original magnification, 10×. Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Survival of WT and IL-8 TG mice after Gal/ET treatment. WT and IL-8 TG mice were treated with Gal/ET and monitored for 24h or until they reached a moribund state. Graph depicts survival over the 24-h interval (14% WT vs. 50% IL-8 TG, P<0.001). Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Quantitative assessment of hepatic apoptosis in WT and IL-8 TG mice after Gal/ET. Panel a depicts the number of TUNEL-positive cells counted in the livers of WT and IL-8 TG mice 6h after Gal/ET (P=0.0002). Panel b depicts caspase-3 activity in WT and IL-8 TG livers 6h after Gal/ET (P=0.03). Values represent mean±SE for n=18. Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Basal hepatic expression of genes relevant to apoptosis in WT and IL-8 TG mice. Autoradiograms illustrate the hepatic expression of genes encoding caspases (left panel) and Bcl-2 family members (right panel) in untreated WT and IL-8 TG mice. There was no difference between the two groups in any of the mRNAs examined. Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Basal hepatic expression of proteins relevant to apoptosis in WT and IL-8 TG mice. Autoradiograms depict hepatic expression of proteins encoding TNF receptor 1 (TNFR1), procaspases-3, -8, and -9, Bid, Bcl-xL, and the IAPs cIAP-1, cIAP-2 and XIAP in untreated mice. β-actin is included as a control for protein content. cIAP-1 was undetectable in untreated livers; for the remainder of the proteins, expression was similar in WT and IL-8 TG mice. Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Expression and cleavage of apoptotic proteins in WT and IL-8 TG livers 6h after Gal/ET. Western blots illustrate proteins relevant to apoptosis in the livers of WT and IL-8 TG mice. Immunoblots for Smac and cytochrome c were performed with purified liver cytosol (see Section 2); all others were performed with whole liver homogenate (see Section 2). 6h after Gal/ET, IL-8 TG mice showed less of the 37-kDa cleavage product of pro-caspase-9 than IL-8 TG mice. They also exhibited a lesser degree of Smac and cytochrome c release into the cytosol, and reduced generation of truncated Bid (15kDa). By contrast, WT and IL-8 TG mice demonstrated similar degrees of procaspase-8 cleavage (from 55kDa to 43/41kDa) in response to Gal/ET. The 20-kDa cleavage product of caspase-8 was not visualized. Additional immunoblots show that hepatic expression of Bcl-xL, A1/Bfl-1 and FADD were comparable in WT and IL-8 TG mice after Gal/ET. Members of the IAP family (cIAP-1, cIAP-2 and XIAP) were also unaffected by IL-8. Survivin was undetectable in either WT or IL-8 TG liver after Gal/ET (not shown). β-actin is shown as a control for protein content. *signifies a non-specific band of immunoreactivity. Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Phosphorylation of Akt and Bad in the livers of WT and IL-8 TG mice in response to Gal/ET. Autoradiogram illustrates Akt and Bad and their phosphorylated forms in mouse liver either before or 6h after Gal/ET treatment. After Gal/ET, phospho-Akt (P-Akt) and phospho-Bad (P-Bad) are both more abundant in IL-8 TG than WT mice. Densitometry indicated that the P-Akt/Akt ratio in Gal/ET-treated IL-8 TG mice was 28% higher than that in WT mice (P<0.05). Journal of Hepatology 2006 44, 359-367DOI: (10.1016/j.jhep.2005.06.022) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions